Date:
22-May-26
Action:
Buy
Notifier:
Amy Walker
(CEO)
Price:
509.00
Amount:
1,863
Holding:
48,529
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
(Sharecast News) - 4basebio said on Wednesday that it had signed a clinical supply agreement with a cancer immunotherapy company to provide GMP-grade opDNA starting material for a Phase II clinical tr...
Date:
20-May-26
Time:
7:00 am
Source:
PRN
4basebio PLC - Cambridge, England-based life sciences company - Appoints Richard Bungay as chief financial officer. Bungay will assume the role from July 2026, succeeding David Roth. Bungay previously...
(Sharecast News) - 4basebio appointed Richard Bungay as chief financial officer on Thursday, as the synthetic DNA specialist prepares for what it described as a phase of accelerated commercial growth.
4basebio PLC - Cambridge, England-based life sciences company - Launches high-capacity single stranded-DNA for therapeutics. The company says the platform, ssDNA, will "accelerate the development of s...
(Sharecast News) - 4basebio said on Monday that it had commercially launched a high-capacity single-stranded DNA product line aimed at supporting the development of gene editing, cell engineering and...